Literature DB >> 23414635

Central lymph node dissection in patients with papillary thyroid cancer: a population level analysis of 14,257 cases.

Chineme Enyioha1, Sanziana A Roman, Julie Ann Sosa.   

Abstract

BACKGROUND: This study analyzes the impact of demographics and tumor size on the use of central compartment lymph node dissection (CLND) for papillary thyroid cancer (PTC) in the United States.
METHODS: Adult patients with PTC and the follicular variant of PTC who underwent thyroidectomy with or without CLND and were reported in the Surveillance Epidemiology and End Results (SEER) database from 2004 to 2008 were included. Bivariate and multivariate analyses were performed to determine the effects of demographic and clinical characteristics on the likelihood of a patient undergoing CLND.
RESULTS: Of 14,257 patients included, 80.3% were women, 84.3% were white, average age was 50.1 years, and 37.1% had CLND. Over 5 years, there was an 18.3% increase in CLND, with the greatest increase seen in patients with T1 tumors (23.2%). Patients who were older, men, black, and from the South were less likely to undergo CLND; however, there were no differences in the total number of lymph nodes examined based on patient demographics or the year of their thyroid cancer diagnoses.
CONCLUSIONS: Being older, black, and from the South are negatively associated with CLND. This practice variation suggests potential disparity in access and quality of surgical care for PTC in the United States.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23414635     DOI: 10.1016/j.amjsurg.2012.06.012

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  7 in total

Review 1.  Differentiated thyroid cancer-personalized therapies to prevent overtreatment.

Authors:  Markus Luster; Theresia Weber; Frederik A Verburg
Journal:  Nat Rev Endocrinol       Date:  2014-07-01       Impact factor: 43.330

2.  Preferential Use of Total Thyroidectomy without Prophylactic Central Lymph Node Dissection for Early-Stage Papillary Thyroid Cancer: Oncologic Outcomes in an Integrated Health Plan.

Authors:  Meena Said; Michele Fujimoto; Cara Franken; Sunee Woo; Brooke Vuong; Philip I Haigh
Journal:  Perm J       Date:  2016-09-30

3.  Frozen section analysis of central lymph nodes in papillary thyroid cancer: the significance in determining the extent of surgery.

Authors:  Min Jhi Kim; Hee Jun Kim; Cheong Soo Park; Bup-Woo Kim
Journal:  Gland Surg       Date:  2022-04

Review 4.  The pros and cons of prophylactic central neck dissection in papillary thyroid carcinoma.

Authors:  Anthony R Glover; Justin S Gundara; Olov Norlén; James C Lee; Stan B Sidhu
Journal:  Gland Surg       Date:  2013-11

5.  Patterns of structural recurrence in papillary thyroid cancer.

Authors:  Schelto Kruijff; Japke F Petersen; Paul Chen; Ahmed M Aniss; Roderick J Clifton-Bligh; Stan B Sidhu; Leigh W Delbridge; Anthony J Gill; Diana Learoyd; Mark S Sywak
Journal:  World J Surg       Date:  2014-03       Impact factor: 3.352

6.  An Update of the Appropriate Treatment Strategies in Anaplastic Thyroid Cancer: A Population-Based Study of 735 Patients.

Authors:  Nai-Si Huang; Xiao Shi; Bo-Wen Lei; Wen-Jun Wei; Zhong-Wu Lu; Peng-Cheng Yu; Yu Wang; Qing-Hai Ji; Yu-Long Wang
Journal:  Int J Endocrinol       Date:  2019-02-19       Impact factor: 3.257

7.  Lymphatic Vessel Invasion in Routine Pathology Reports of Papillary Thyroid Cancer.

Authors:  Costanza Chiapponi; Hakan Alakus; Matthias Schmidt; Michael Faust; Christiane J Bruns; Reinhard Büttner; Marie-Lisa Eich; Anne M Schultheis
Journal:  Front Med (Lausanne)       Date:  2022-02-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.